Multiple biomarker panels for cardiovascular risk assessment
New England Journal of Medicine (Impact Factor: 54.42). 06/2008; 358(20):2172-4. DOI: 10.1056/NEJMe0801721
- [Show abstract] [Hide abstract]
ABSTRACT: Multiple biomarker panels of common, multifactorial diseases - such as cardiovascular and Alzheimer’s disease - have recently been described, facilitating the diagnosis and risk management of these diseases. In principle, a biomarker is an indicator of a biochemical feature or facet that can be used to diagnose or monitor the progress of a disease. Detection technology has been identified for possible types of biomarkers in primary open-angle glaucoma (POAG). We will summarize known biomarkers with the intent of cataloging the biomarkers in the aqueous humor, trabecular meshwork (TM), optic nerve, and blood in patients with POAG. To facilitate comparisons and to offer mechanistic clues, biochemical changes such as up- or downregulation of proteins that have been reported in POAG are organized into three categories: namely, extracellular matrix (ECM) changes, cytokine/signaling molecules, and aging/stress (listed respectively in Tables 82.1, 82.2, and 82.3).
- Clinical Research in Cardiology Supplements 04/2010; 5:21-26. DOI:10.1007/s11789-010-0008-9
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.